- Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types
- Teleflex’s Climate Targets Validated by the Science Based Targets Initiative
- Teleflex Announces Quarterly Dividend
- Teleflex Reports Fourth Quarter and Full Year 2023 Financial Results
- Teleflex to Present at the 45th Annual Raymond James Institutional Investors Conference
- Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information
- Teleflex now offers its Titan SGS™ Stapler with Staple Line Reinforcement
- Teleflex to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Teleflex Awarded Peripheral Access Agreement with Premier, Inc.
- Teleflex Announces First Patient Enrollment in ACCESS-MANTA™ Registry
More ▼
Key statistics
As of last trade, Teleflex Inc (TFX:NYQ) traded at 208.61, 17.44% above the 52 week low of 177.63 set on Oct 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 210.67 |
---|---|
High | 210.67 |
Low | 207.09 |
Bid | 208.05 |
Offer | 208.64 |
Previous close | 210.10 |
Average volume | 236.77k |
---|---|
Shares outstanding | 47.10m |
Free float | 46.98m |
P/E (TTM) | 27.80 |
Market cap | 9.90bn USD |
EPS (TTM) | 7.56 USD |
Annual div (ADY) | 1.36 USD |
---|---|
Annual div yield (ADY) | 0.65% |
Div ex-date | Feb 29 2024 |
Div pay-date | Mar 15 2024 |
Data delayed at least 15 minutes, as of Apr 17 2024 19:35 BST.
More ▼